Aaron Grossberg

Has grant

Assistant Professor

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Aaron Grossberg is an Assistant Professor at Oregon Health & Science University. His research focuses on pancreatic cancer, particularly in the areas of early detection, chemotherapy protocols, and cachexia management. He has also contributed to studies on COVID-19 dynamics and sarcopenia in cancer patients. His recent work underscores the importance of multidisciplinary approaches in cancer treatment.

Recent Grants

Grant: Close

Hepatic metabolic reprogramming drives pancreatic cancer cachexia

Open Date: 2020-07-01

Close Date: 2025-06-01

Grant: Close

The Role of Orexin Signaling in Brain Radiation-induced Fatigue

Open Date: 2016-07-01

Close Date: 2016-07-01

Grant: Close

Inflammatory Cytokine regulation of POMC and Orexin neurons in cachexia.

Open Date: 2009-09-01

Close Date: 2013-06-23

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Steven Frank

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Skye C. Mayo

UNITED STATES

View details

Vivian Salama

Research Assistant Professor

West Virginia University

UNITED STATES

View details

Maedeh Mohebnasab

Assistant Professor

UPMC Presbyterian

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aaron Grossberg

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients

Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis

Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma

The multidisciplinary management of cholangiocarcinoma

Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications

Spatial Prediction of COVID-19 Pandemic Dynamics in the United States

Muscle and adipose tissue segmentations at the third cervical vertebral level in patients with head and neck cancer

Use of a Therapeutic Trial of Graduated Neoadjuvant Radiation Therapy for Locally Advanced Esophageal Cancer in a Patient With Fanconi Anemia

Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy

Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy

Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Collaborators (4)

Steven Frank

Skye C. Mayo

Vivian Salama

Maedeh Mohebnasab

Make your next move.